Gene Symbol | Gene ID | Gene Info |
---|---|---|
CEBPA
|
ENSG00000245848.2 | CCAAT enhancer binding protein alpha |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr19_33793047_33793234 | CEBPA | 330 | 0.600592 | -0.56 | 1.1e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr9_33715106_33715257 | 4.28 |
TRBV26OR9-2 |
T cell receptor beta variable 26/OR9-2 (pseudogene) |
19416 |
0.14 |
chr9_114603944_114604095 | 3.46 |
ENSG00000206907 |
. |
1911 |
0.36 |
chr7_127641291_127641582 | 3.25 |
LRRC4 |
leucine rich repeat containing 4 |
29622 |
0.21 |
chr20_1515264_1515530 | 3.21 |
ENSG00000252103 |
. |
5592 |
0.15 |
chr1_246183327_246183692 | 3.00 |
RP11-83A16.1 |
|
13344 |
0.27 |
chr10_114673586_114673994 | 2.98 |
RP11-57H14.3 |
|
25296 |
0.18 |
chr2_208839065_208839250 | 2.91 |
PLEKHM3 |
pleckstrin homology domain containing, family M, member 3 |
3017 |
0.26 |
chr4_140765342_140765493 | 2.87 |
MAML3 |
mastermind-like 3 (Drosophila) |
45789 |
0.15 |
chr8_56824785_56824994 | 2.86 |
ENSG00000216204 |
. |
3369 |
0.19 |
chr1_153365212_153365363 | 2.83 |
S100A8 |
S100 calcium binding protein A8 |
1623 |
0.24 |
chr5_81190738_81191247 | 2.83 |
ATG10 |
autophagy related 10 |
76852 |
0.1 |
chr1_184123052_184123415 | 2.82 |
ENSG00000199840 |
. |
17724 |
0.25 |
chr17_9768998_9769149 | 2.77 |
GLP2R |
glucagon-like peptide 2 receptor |
23271 |
0.16 |
chr7_141589207_141589507 | 2.76 |
OR9A1P |
olfactory receptor, family 9, subfamily A, member 1 pseudogene |
2409 |
0.17 |
chr9_21252315_21252536 | 2.69 |
IFNA14 |
interferon, alpha 14 |
12447 |
0.12 |
chr9_94191209_94191360 | 2.65 |
NFIL3 |
nuclear factor, interleukin 3 regulated |
5140 |
0.32 |
chr2_201958452_201958603 | 2.64 |
ENSG00000252148 |
. |
13962 |
0.12 |
chr22_39347778_39348025 | 2.63 |
APOBEC3A |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A |
855 |
0.52 |
chr3_142556476_142556627 | 2.61 |
ENSG00000251787 |
. |
36502 |
0.15 |
chr13_77923535_77923686 | 2.56 |
MYCBP2 |
MYC binding protein 2, E3 ubiquitin protein ligase |
22431 |
0.26 |
chr6_90089168_90089467 | 2.55 |
UBE2J1 |
ubiquitin-conjugating enzyme E2, J1 |
26750 |
0.15 |
chr13_53402555_53402845 | 2.55 |
ENSG00000211579 |
. |
18521 |
0.21 |
chr20_59223778_59223929 | 2.51 |
ENSG00000265617 |
. |
84233 |
0.11 |
chr13_78820617_78820768 | 2.48 |
ENSG00000200686 |
. |
108771 |
0.07 |
chr2_30667277_30667428 | 2.48 |
LCLAT1 |
lysocardiolipin acyltransferase 1 |
2740 |
0.33 |
chr20_55072351_55072502 | 2.48 |
ENSG00000238294 |
. |
21727 |
0.11 |
chr1_182429376_182429658 | 2.47 |
RGSL1 |
regulator of G-protein signaling like 1 |
6998 |
0.24 |
chr19_43075305_43075456 | 2.46 |
CEACAM1 |
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
9994 |
0.19 |
chr17_34406_34557 | 2.46 |
DOC2B |
double C2-like domains, beta |
3054 |
0.3 |
chr4_140761836_140762178 | 2.44 |
ENSG00000252233 |
. |
46420 |
0.15 |
chr10_49932582_49932733 | 2.41 |
WDFY4 |
WDFY family member 4 |
14906 |
0.23 |
chr1_150760218_150760491 | 2.39 |
CTSK |
cathepsin K |
19556 |
0.12 |
chr12_40316486_40316637 | 2.35 |
ENSG00000199571 |
. |
102876 |
0.07 |
chr2_171600843_171600994 | 2.34 |
SP5 |
Sp5 transcription factor |
29057 |
0.12 |
chr9_114554047_114554198 | 2.34 |
C9orf84 |
chromosome 9 open reading frame 84 |
3090 |
0.29 |
chr12_68666381_68666532 | 2.34 |
IL22 |
interleukin 22 |
19069 |
0.2 |
chr20_39919427_39919896 | 2.32 |
ENSG00000263989 |
. |
444 |
0.84 |
chr3_167238880_167239031 | 2.32 |
WDR49 |
WD repeat domain 49 |
10022 |
0.26 |
chr12_8229057_8229208 | 2.31 |
NECAP1 |
NECAP endocytosis associated 1 |
5675 |
0.16 |
chr2_209219860_209220011 | 2.31 |
ENSG00000265454 |
. |
14412 |
0.19 |
chr9_3736373_3736624 | 2.30 |
RP11-252M18.3 |
|
139086 |
0.05 |
chr2_24819191_24819342 | 2.30 |
NCOA1 |
nuclear receptor coactivator 1 |
11856 |
0.22 |
chr14_22173215_22173506 | 2.30 |
OR4E2 |
olfactory receptor, family 4, subfamily E, member 2 |
40063 |
0.15 |
chr9_86077911_86078062 | 2.30 |
ENSG00000238608 |
. |
10798 |
0.2 |
chr19_54772890_54773041 | 2.27 |
ENSG00000212314 |
. |
5052 |
0.09 |
chr7_75580955_75581106 | 2.26 |
POR |
P450 (cytochrome) oxidoreductase |
2364 |
0.25 |
chr1_21164177_21164328 | 2.25 |
ENSG00000251914 |
. |
3482 |
0.25 |
chr5_59553822_59554095 | 2.24 |
ENSG00000202017 |
. |
46020 |
0.18 |
chr10_34685690_34685841 | 2.24 |
PARD3 |
par-3 family cell polarity regulator |
24304 |
0.28 |
chr5_176337499_176337650 | 2.20 |
HK3 |
hexokinase 3 (white cell) |
11241 |
0.21 |
chr7_117951698_117951849 | 2.20 |
ANKRD7 |
ankyrin repeat domain 7 |
86822 |
0.1 |
chr7_17869944_17870095 | 2.19 |
SNX13 |
sorting nexin 13 |
110072 |
0.07 |
chr2_174889480_174890119 | 2.19 |
SP3 |
Sp3 transcription factor |
59369 |
0.15 |
chr15_52843365_52843599 | 2.18 |
ARPP19 |
cAMP-regulated phosphoprotein, 19kDa |
6459 |
0.19 |
chr11_95002755_95002906 | 2.17 |
RP11-712B9.2 |
|
37095 |
0.18 |
chr4_86619161_86619509 | 2.16 |
ENSG00000266421 |
. |
24286 |
0.25 |
chr4_36269403_36269695 | 2.16 |
RP11-431M7.3 |
|
11409 |
0.2 |
chr5_148422492_148422643 | 2.16 |
SH3TC2 |
SH3 domain and tetratricopeptide repeats 2 |
1458 |
0.37 |
chr9_101513075_101513226 | 2.15 |
ANKS6 |
ankyrin repeat and sterile alpha motif domain containing 6 |
26558 |
0.18 |
chr3_187840204_187840389 | 2.15 |
LPP |
LIM domain containing preferred translocation partner in lipoma |
30776 |
0.18 |
chr12_29311969_29312148 | 2.14 |
FAR2 |
fatty acyl CoA reductase 2 |
9925 |
0.26 |
chr6_124755735_124755886 | 2.14 |
NKAIN2 |
Na+/K+ transporting ATPase interacting 2 |
152426 |
0.05 |
chr6_12049983_12050134 | 2.14 |
HIVEP1 |
human immunodeficiency virus type I enhancer binding protein 1 |
34238 |
0.21 |
chr2_68639578_68639939 | 2.14 |
AC015969.3 |
|
47042 |
0.11 |
chr6_170682652_170683082 | 2.14 |
RP1-140C12.2 |
|
40360 |
0.14 |
chr2_2718286_2718437 | 2.14 |
ENSG00000263570 |
. |
302741 |
0.01 |
chr20_17948040_17948617 | 2.14 |
SNX5 |
sorting nexin 5 |
773 |
0.48 |
chr15_77769425_77769576 | 2.13 |
HMG20A |
high mobility group 20A |
1135 |
0.6 |
chr6_138056023_138056174 | 2.13 |
ENSG00000216097 |
. |
18013 |
0.23 |
chr5_40029900_40030051 | 2.12 |
ENSG00000199361 |
. |
239685 |
0.02 |
chr17_59244465_59244616 | 2.12 |
RP11-136H19.1 |
|
31215 |
0.19 |
chr15_58540473_58540733 | 2.12 |
ALDH1A2 |
aldehyde dehydrogenase 1 family, member A2 |
30859 |
0.22 |
chr18_53829980_53830344 | 2.12 |
ENSG00000201816 |
. |
83337 |
0.11 |
chr11_11577890_11578041 | 2.11 |
RP11-483L5.1 |
|
13666 |
0.25 |
chr4_130544500_130544729 | 2.10 |
ENSG00000222861 |
. |
237041 |
0.02 |
chr4_74757787_74757938 | 2.10 |
CXCL1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
22741 |
0.14 |
chr3_60841750_60841928 | 2.10 |
ENSG00000212211 |
. |
438 |
0.91 |
chr3_195171618_195171863 | 2.10 |
ACAP2 |
ArfGAP with coiled-coil, ankyrin repeat and PH domains 2 |
7933 |
0.2 |
chr21_39792072_39792223 | 2.09 |
ERG |
v-ets avian erythroblastosis virus E26 oncogene homolog |
78198 |
0.11 |
chr2_149513448_149513599 | 2.09 |
EPC2 |
enhancer of polycomb homolog 2 (Drosophila) |
65740 |
0.12 |
chr2_135641742_135641893 | 2.09 |
ENSG00000263783 |
. |
26427 |
0.15 |
chr3_120311624_120311775 | 2.08 |
NDUFB4 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 4, 15kDa |
3457 |
0.31 |
chr1_76691305_76691456 | 2.08 |
ST6GALNAC3 |
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 |
150976 |
0.04 |
chr1_221204367_221204518 | 2.07 |
HLX |
H2.0-like homeobox |
149858 |
0.04 |
chr8_9963230_9963381 | 2.07 |
MSRA |
methionine sulfoxide reductase A |
10068 |
0.21 |
chr20_51919785_51919936 | 2.07 |
RP11-15M15.2 |
|
94616 |
0.07 |
chr22_22126215_22126366 | 2.06 |
ENSG00000200985 |
. |
20433 |
0.13 |
chr1_186964094_186964245 | 2.06 |
PLA2G4A |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
166047 |
0.04 |
chr17_61823716_61823867 | 2.06 |
STRADA |
STE20-related kinase adaptor alpha |
4461 |
0.16 |
chr5_79644134_79644285 | 2.06 |
ENSG00000206774 |
. |
17442 |
0.16 |
chr14_100507988_100508139 | 2.05 |
EVL |
Enah/Vasp-like |
22344 |
0.15 |
chr7_18218839_18218999 | 2.05 |
ENSG00000221393 |
. |
51987 |
0.15 |
chr20_48344212_48344363 | 2.05 |
ENSG00000264946 |
. |
5801 |
0.2 |
chr20_20760824_20761172 | 2.05 |
ENSG00000264361 |
. |
41624 |
0.19 |
chr15_93791035_93791186 | 2.04 |
ENSG00000212063 |
. |
38442 |
0.18 |
chr7_36143881_36144032 | 2.04 |
RP11-196O2.1 |
|
9058 |
0.21 |
chr3_129541646_129541903 | 2.04 |
ENSG00000252786 |
. |
3154 |
0.22 |
chr3_71867495_71867646 | 2.03 |
ENSG00000239250 |
. |
8758 |
0.22 |
chr12_62360450_62360601 | 2.02 |
FAM19A2 |
family with sequence similarity 19 (chemokine (C-C motif)-like), member A2 |
138184 |
0.05 |
chr3_59320438_59320589 | 2.02 |
C3orf67 |
chromosome 3 open reading frame 67 |
284703 |
0.01 |
chr1_56716174_56716325 | 2.01 |
ENSG00000223307 |
. |
126841 |
0.06 |
chr16_50077705_50077856 | 2.01 |
CNEP1R1 |
CTD nuclear envelope phosphatase 1 regulatory subunit 1 |
17709 |
0.15 |
chr12_1727335_1727720 | 2.01 |
WNT5B |
wingless-type MMTV integration site family, member 5B |
1305 |
0.46 |
chr11_127424987_127425138 | 2.00 |
ENSG00000223315 |
. |
147316 |
0.05 |
chr11_130153287_130153576 | 1.99 |
ZBTB44 |
zinc finger and BTB domain containing 44 |
21647 |
0.2 |
chr1_240076510_240076661 | 1.98 |
CHRM3-AS1 |
CHRM3 antisense RNA 1 |
13413 |
0.28 |
chr5_15254824_15254975 | 1.98 |
ENSG00000202269 |
. |
143870 |
0.05 |
chr7_37711541_37711746 | 1.98 |
GPR141 |
G protein-coupled receptor 141 |
11757 |
0.23 |
chr18_75591325_75591476 | 1.97 |
ENSG00000252260 |
. |
15877 |
0.31 |
chr11_59823736_59824267 | 1.97 |
MS4A3 |
membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific) |
59 |
0.97 |
chr10_7088660_7089557 | 1.96 |
SFMBT2 |
Scm-like with four mbt domains 2 |
361599 |
0.01 |
chr11_34361279_34361470 | 1.96 |
ABTB2 |
ankyrin repeat and BTB (POZ) domain containing 2 |
17428 |
0.25 |
chr6_160226795_160227041 | 1.96 |
PNLDC1 |
poly(A)-specific ribonuclease (PARN)-like domain containing 1 |
5612 |
0.13 |
chr1_203250946_203251097 | 1.96 |
BTG2 |
BTG family, member 2 |
23643 |
0.15 |
chr16_11918383_11918534 | 1.96 |
RSL1D1 |
ribosomal L1 domain containing 1 |
26444 |
0.11 |
chr3_169695620_169695771 | 1.96 |
SEC62-AS1 |
SEC62 antisense RNA 1 |
7808 |
0.14 |
chr13_79857188_79857339 | 1.95 |
RBM26 |
RNA binding motif protein 26 |
58084 |
0.15 |
chr4_75204662_75204813 | 1.94 |
ENSG00000265720 |
. |
12134 |
0.18 |
chr1_36952574_36952861 | 1.94 |
CSF3R |
colony stimulating factor 3 receptor (granulocyte) |
3838 |
0.2 |
chr14_107075728_107075879 | 1.94 |
IGHV3-57 |
immunoglobulin heavy variable 3-57 (pseudogene) |
617 |
0.3 |
chr20_21320308_21320459 | 1.94 |
XRN2 |
5'-3' exoribonuclease 2 |
35951 |
0.16 |
chr9_79234557_79234812 | 1.93 |
PRUNE2 |
prune homolog 2 (Drosophila) |
32781 |
0.17 |
chr20_48448761_48449291 | 1.93 |
ENSG00000252123 |
. |
4497 |
0.19 |
chr12_104084960_104085111 | 1.93 |
RP11-341G23.3 |
|
21851 |
0.15 |
chr12_129423597_129423748 | 1.92 |
GLT1D1 |
glycosyltransferase 1 domain containing 1 |
74991 |
0.11 |
chr1_56981658_56981809 | 1.92 |
PPAP2B |
phosphatidic acid phosphatase type 2B |
63508 |
0.14 |
chr20_39128190_39128341 | 1.92 |
ENSG00000252434 |
. |
82750 |
0.11 |
chr12_10130615_10130766 | 1.91 |
CLEC12A |
C-type lectin domain family 12, member A |
6494 |
0.14 |
chr16_3793256_3793407 | 1.91 |
CREBBP |
CREB binding protein |
8478 |
0.19 |
chrX_96482550_96482701 | 1.91 |
ENSG00000265260 |
. |
113420 |
0.07 |
chr11_95015604_95015755 | 1.91 |
RP11-712B9.2 |
|
49944 |
0.15 |
chr7_106007305_106007456 | 1.90 |
NAMPT |
nicotinamide phosphoribosyltransferase |
80608 |
0.1 |
chr8_22579357_22579508 | 1.89 |
ENSG00000253125 |
. |
25584 |
0.12 |
chr2_113597075_113597265 | 1.89 |
IL1B |
interleukin 1, beta |
2690 |
0.24 |
chr6_43770852_43771006 | 1.89 |
VEGFA |
vascular endothelial growth factor A |
28839 |
0.16 |
chr5_95624565_95624716 | 1.89 |
ENSG00000206997 |
. |
78709 |
0.1 |
chrX_65270014_65270332 | 1.88 |
VSIG4 |
V-set and immunoglobulin domain containing 4 |
10206 |
0.23 |
chr15_69653276_69653615 | 1.87 |
ENSG00000252972 |
. |
6479 |
0.14 |
chr2_161423362_161423513 | 1.87 |
RBMS1 |
RNA binding motif, single stranded interacting protein 1 |
73132 |
0.12 |
chr22_30675082_30675729 | 1.87 |
GATSL3 |
GATS protein-like 3 |
10191 |
0.09 |
chr10_111975212_111975532 | 1.87 |
MXI1 |
MAX interactor 1, dimerization protein |
5383 |
0.23 |
chr17_33177114_33177265 | 1.87 |
CCT6B |
chaperonin containing TCP1, subunit 6B (zeta 2) |
111232 |
0.05 |
chr16_84397489_84397640 | 1.87 |
ATP2C2 |
ATPase, Ca++ transporting, type 2C, member 2 |
4569 |
0.22 |
chr13_109597145_109597296 | 1.86 |
MYO16 |
myosin XVI |
58703 |
0.16 |
chr3_171686128_171686310 | 1.86 |
FNDC3B |
fibronectin type III domain containing 3B |
71199 |
0.1 |
chr9_21983229_21983380 | 1.86 |
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
8207 |
0.14 |
chr4_77298856_77299007 | 1.85 |
ENSG00000212368 |
. |
21063 |
0.14 |
chr4_173870136_173870287 | 1.85 |
ENSG00000241652 |
. |
192583 |
0.03 |
chr14_56574893_56575044 | 1.85 |
PELI2 |
pellino E3 ubiquitin protein ligase family member 2 |
9564 |
0.23 |
chr7_139561651_139561816 | 1.85 |
TBXAS1 |
thromboxane A synthase 1 (platelet) |
32623 |
0.21 |
chr6_87808904_87809055 | 1.85 |
CGA |
glycoprotein hormones, alpha polypeptide |
4155 |
0.23 |
chr2_75105185_75105336 | 1.85 |
HK2 |
hexokinase 2 |
42963 |
0.16 |
chr4_86578746_86578897 | 1.85 |
ARHGAP24 |
Rho GTPase activating protein 24 |
53515 |
0.16 |
chr2_73841384_73841535 | 1.84 |
NAT8 |
N-acetyltransferase 8 (GCN5-related, putative) |
28061 |
0.18 |
chr5_17445781_17445932 | 1.84 |
ENSG00000201715 |
. |
100131 |
0.08 |
chr9_35834312_35834712 | 1.84 |
TMEM8B |
transmembrane protein 8B |
4999 |
0.1 |
chr9_126569247_126569398 | 1.83 |
RP11-417B4.2 |
|
70606 |
0.11 |
chr1_28218344_28219275 | 1.83 |
RPA2 |
replication protein A2, 32kDa |
4787 |
0.13 |
chr8_103828512_103828810 | 1.83 |
AZIN1 |
antizyme inhibitor 1 |
41669 |
0.13 |
chr5_62038688_62038839 | 1.83 |
LRRC70 |
leucine rich repeat containing 70 |
164061 |
0.04 |
chr8_129417346_129417497 | 1.83 |
ENSG00000201782 |
. |
184671 |
0.03 |
chr20_5668640_5669158 | 1.83 |
C20orf196 |
chromosome 20 open reading frame 196 |
62140 |
0.12 |
chr13_77294627_77294851 | 1.82 |
KCTD12 |
potassium channel tetramerization domain containing 12 |
165786 |
0.04 |
chr7_106059873_106060161 | 1.82 |
CTB-111H14.1 |
|
85268 |
0.09 |
chrX_124430487_124430638 | 1.82 |
ENSG00000263886 |
. |
8937 |
0.33 |
chr2_64414478_64414629 | 1.82 |
AC074289.1 |
|
19556 |
0.23 |
chr7_120436672_120436823 | 1.82 |
RP4-797C5.2 |
|
44179 |
0.15 |
chr5_77087322_77087473 | 1.82 |
TBCA |
tubulin folding cofactor A |
15212 |
0.29 |
chr12_116722050_116722330 | 1.82 |
MED13L |
mediator complex subunit 13-like |
7047 |
0.24 |
chr7_77082891_77083367 | 1.81 |
ENSG00000238453 |
. |
30024 |
0.19 |
chr17_2968117_2968268 | 1.81 |
OR1D5 |
olfactory receptor, family 1, subfamily D, member 5 |
1291 |
0.46 |
chr10_11682326_11682477 | 1.81 |
USP6NL |
USP6 N-terminal like |
28648 |
0.19 |
chr10_5275618_5276004 | 1.80 |
AKR1CL1 |
aldo-keto reductase family 1, member C-like 1 |
31362 |
0.13 |
chr19_30748039_30748190 | 1.80 |
AC005597.1 |
|
28492 |
0.21 |
chr10_89857477_89857628 | 1.80 |
ENSG00000200891 |
. |
103100 |
0.07 |
chr12_68761789_68762303 | 1.80 |
MDM1 |
Mdm1 nuclear protein homolog (mouse) |
35885 |
0.21 |
chr2_144305747_144305898 | 1.80 |
RP11-570L15.2 |
|
23852 |
0.2 |
chr3_169318736_169318887 | 1.80 |
RP11-3K16.2 |
|
22928 |
0.19 |
chr5_88109213_88109507 | 1.80 |
MEF2C |
myocyte enhancer factor 2C |
10245 |
0.27 |
chr12_27242184_27242645 | 1.80 |
C12orf71 |
chromosome 12 open reading frame 71 |
6967 |
0.23 |
chr14_101308246_101309004 | 1.79 |
ENSG00000214548 |
. |
7020 |
0.04 |
chr10_6607576_6607835 | 1.79 |
PRKCQ |
protein kinase C, theta |
14496 |
0.3 |
chr6_51167339_51167725 | 1.79 |
ENSG00000212532 |
. |
161956 |
0.04 |
chr4_40559872_40560023 | 1.79 |
RBM47 |
RNA binding motif protein 47 |
41957 |
0.15 |
chr3_4906285_4906436 | 1.79 |
ENSG00000239126 |
. |
14026 |
0.2 |
chr7_128654940_128655091 | 1.79 |
TNPO3 |
transportin 3 |
39922 |
0.11 |
chr10_10705153_10705304 | 1.79 |
CELF2 |
CUGBP, Elav-like family member 2 |
342031 |
0.01 |
chr15_49279459_49279610 | 1.79 |
ENSG00000207105 |
. |
8685 |
0.15 |
chr12_11840393_11840742 | 1.78 |
ETV6 |
ets variant 6 |
37779 |
0.2 |
chr5_94279999_94280150 | 1.78 |
MCTP1 |
multiple C2 domains, transmembrane 1 |
4194 |
0.3 |
chr10_30685926_30686077 | 1.78 |
ENSG00000239625 |
. |
30754 |
0.13 |
chr10_114911157_114911387 | 1.78 |
TCF7L2 |
transcription factor 7-like 2 (T-cell specific, HMG-box) |
430 |
0.91 |
chr12_635145_635296 | 1.78 |
B4GALNT3 |
beta-1,4-N-acetyl-galactosaminyl transferase 3 |
17079 |
0.18 |
chr4_154582389_154582540 | 1.77 |
RP11-153M7.3 |
|
16947 |
0.19 |
chr1_224567153_224567600 | 1.77 |
ENSG00000266618 |
. |
18637 |
0.14 |
chr1_86354686_86354837 | 1.77 |
ENSG00000201620 |
. |
5280 |
0.33 |
chr2_158903146_158903297 | 1.77 |
UPP2 |
uridine phosphorylase 2 |
51510 |
0.13 |
chr5_124254216_124254509 | 1.77 |
ZNF608 |
zinc finger protein 608 |
169862 |
0.03 |
chr10_94453199_94453425 | 1.77 |
HHEX |
hematopoietically expressed homeobox |
1700 |
0.37 |
chr12_92483506_92484002 | 1.77 |
C12orf79 |
chromosome 12 open reading frame 79 |
47043 |
0.14 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.0 | GO:0032632 | interleukin-3 production(GO:0032632) |
1.6 | 4.9 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
1.6 | 4.8 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
1.4 | 4.2 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
1.4 | 2.7 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
1.2 | 6.2 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
1.2 | 5.0 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
1.2 | 3.7 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
1.2 | 3.6 | GO:0071436 | sodium ion export(GO:0071436) |
1.2 | 3.5 | GO:0070672 | response to interleukin-15(GO:0070672) |
1.2 | 2.4 | GO:0010193 | response to ozone(GO:0010193) |
1.1 | 4.5 | GO:0003351 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
1.1 | 3.3 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
1.1 | 2.1 | GO:0060437 | lung growth(GO:0060437) |
1.1 | 3.2 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
1.0 | 4.0 | GO:0035930 | corticosteroid hormone secretion(GO:0035930) regulation of steroid hormone secretion(GO:2000831) regulation of corticosteroid hormone secretion(GO:2000846) |
1.0 | 10.6 | GO:0006911 | phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
1.0 | 3.8 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.9 | 7.5 | GO:0042119 | neutrophil activation(GO:0042119) |
0.9 | 9.3 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.9 | 0.9 | GO:0052555 | positive regulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052555) positive regulation by symbiont of host immune response(GO:0052556) |
0.9 | 2.8 | GO:0051458 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.9 | 2.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.9 | 3.7 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.9 | 2.7 | GO:0001821 | histamine secretion(GO:0001821) |
0.9 | 2.7 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.9 | 2.7 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.9 | 2.6 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.9 | 1.7 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.9 | 2.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.9 | 0.9 | GO:0001774 | microglial cell activation(GO:0001774) |
0.9 | 2.6 | GO:0035610 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.8 | 2.5 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.8 | 4.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.8 | 2.4 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.8 | 3.8 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.8 | 3.0 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.8 | 3.8 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.8 | 0.8 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.7 | 2.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.7 | 1.5 | GO:0010447 | response to acidic pH(GO:0010447) |
0.7 | 0.7 | GO:0070633 | transepithelial transport(GO:0070633) |
0.7 | 3.5 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.7 | 2.1 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.7 | 3.4 | GO:2000178 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.7 | 4.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.7 | 1.4 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.7 | 2.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.7 | 2.0 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.7 | 3.3 | GO:0032782 | bile acid secretion(GO:0032782) |
0.6 | 0.6 | GO:0002690 | positive regulation of leukocyte chemotaxis(GO:0002690) |
0.6 | 2.6 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.6 | 1.9 | GO:0071692 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.6 | 0.6 | GO:0032898 | neurotrophin production(GO:0032898) |
0.6 | 0.6 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.6 | 1.2 | GO:0070340 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.6 | 1.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.6 | 1.8 | GO:1903224 | endodermal cell fate specification(GO:0001714) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.6 | 2.5 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.6 | 1.8 | GO:0030091 | protein repair(GO:0030091) |
0.6 | 1.2 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.6 | 1.2 | GO:2000192 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
0.6 | 0.6 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.6 | 1.8 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.6 | 2.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.6 | 3.5 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.6 | 1.2 | GO:0052572 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.6 | 3.5 | GO:0008228 | opsonization(GO:0008228) |
0.6 | 2.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.6 | 0.6 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.6 | 0.6 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.6 | 2.8 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.6 | 2.8 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.6 | 1.7 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.6 | 3.3 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.6 | 2.2 | GO:0035751 | lysosomal lumen acidification(GO:0007042) regulation of lysosomal lumen pH(GO:0035751) |
0.5 | 8.8 | GO:0050832 | defense response to fungus(GO:0050832) |
0.5 | 8.2 | GO:0045730 | respiratory burst(GO:0045730) |
0.5 | 1.1 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.5 | 1.6 | GO:0019532 | oxalate transport(GO:0019532) |
0.5 | 0.5 | GO:0048143 | astrocyte activation(GO:0048143) |
0.5 | 1.1 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.5 | 1.6 | GO:0034371 | chylomicron remodeling(GO:0034371) |
0.5 | 1.0 | GO:0035929 | steroid hormone secretion(GO:0035929) |
0.5 | 2.1 | GO:0072583 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.5 | 1.0 | GO:0009405 | pathogenesis(GO:0009405) |
0.5 | 1.0 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.5 | 1.5 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.5 | 3.0 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.5 | 2.0 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of leukocyte degranulation(GO:0043302) positive regulation of mast cell degranulation(GO:0043306) |
0.5 | 1.5 | GO:0044321 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.5 | 1.5 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.5 | 9.4 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.5 | 4.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.5 | 0.5 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.5 | 5.4 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.5 | 1.5 | GO:0010586 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.5 | 1.9 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.5 | 1.5 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.5 | 5.8 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.5 | 1.4 | GO:0007000 | nucleolus organization(GO:0007000) |
0.5 | 1.0 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.5 | 1.9 | GO:0016266 | O-glycan processing(GO:0016266) |
0.5 | 0.5 | GO:0051852 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.5 | 0.9 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.5 | 1.4 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.5 | 0.5 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.5 | 1.9 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.5 | 6.5 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.5 | 0.5 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.5 | 0.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.4 | 0.9 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.4 | 4.4 | GO:0001556 | oocyte maturation(GO:0001556) |
0.4 | 3.6 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.4 | 2.2 | GO:0070570 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.4 | 1.8 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.4 | 1.3 | GO:0045117 | azole transport(GO:0045117) |
0.4 | 2.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.4 | 1.3 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.4 | 3.0 | GO:0006896 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.4 | 2.6 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.4 | 3.0 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.4 | 3.4 | GO:0015671 | oxygen transport(GO:0015671) |
0.4 | 2.1 | GO:0030033 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.4 | 5.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.4 | 1.7 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.4 | 1.2 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.4 | 0.8 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.4 | 0.8 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.4 | 1.6 | GO:0018101 | protein citrullination(GO:0018101) |
0.4 | 1.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.4 | 1.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.4 | 1.2 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.4 | 3.2 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.4 | 2.0 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.4 | 0.8 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.4 | 0.8 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.4 | 1.2 | GO:0043049 | otic placode formation(GO:0043049) |
0.4 | 0.8 | GO:0097576 | vacuole fusion(GO:0097576) |
0.4 | 1.9 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.4 | 2.3 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.4 | 1.9 | GO:0006991 | response to sterol depletion(GO:0006991) |
0.4 | 2.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.4 | 1.2 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.4 | 0.4 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.4 | 0.4 | GO:0032621 | interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) |
0.4 | 1.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.4 | 1.5 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.4 | 0.4 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.4 | 0.7 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.4 | 5.9 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.4 | 0.7 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.4 | 0.7 | GO:0007549 | dosage compensation(GO:0007549) |
0.4 | 1.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.4 | 1.1 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament organization(GO:0031033) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.4 | 1.8 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) positive regulation of hormone biosynthetic process(GO:0046886) |
0.4 | 1.1 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.4 | 2.1 | GO:0015904 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.4 | 0.4 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.3 | 1.0 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.3 | 1.0 | GO:0019985 | translesion synthesis(GO:0019985) |
0.3 | 2.8 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.3 | 1.0 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.3 | 0.3 | GO:0032648 | regulation of interferon-beta production(GO:0032648) |
0.3 | 1.4 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.3 | 0.7 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.3 | 0.7 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.3 | 1.0 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.3 | 1.0 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.3 | 0.3 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.3 | 1.3 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.3 | 1.0 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.3 | 1.3 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
0.3 | 1.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.3 | 0.3 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.3 | 0.7 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.3 | 5.2 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.3 | 0.6 | GO:1901863 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.3 | 1.0 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.3 | 1.6 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.3 | 1.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.3 | 1.6 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.3 | 0.6 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.3 | 0.6 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.3 | 0.9 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.3 | 1.6 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.3 | 1.5 | GO:0016265 | obsolete death(GO:0016265) |
0.3 | 0.3 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
0.3 | 0.3 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.3 | 0.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.3 | 1.5 | GO:0007141 | male meiosis I(GO:0007141) |
0.3 | 0.9 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.3 | 1.5 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.3 | 6.9 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.3 | 1.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 0.6 | GO:0031297 | replication fork processing(GO:0031297) |
0.3 | 1.5 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 0.3 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.3 | 1.8 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.3 | 0.6 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.3 | 1.8 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.3 | 0.9 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.3 | 0.6 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.3 | 1.4 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.3 | 2.6 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.3 | 1.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.3 | 0.9 | GO:0001820 | serotonin secretion(GO:0001820) |
0.3 | 0.8 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.3 | 0.8 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.3 | 0.8 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.3 | 0.8 | GO:0090559 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
0.3 | 0.8 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.3 | 0.6 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.3 | 0.8 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.3 | 0.5 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.3 | 0.3 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.3 | 1.6 | GO:0050957 | equilibrioception(GO:0050957) |
0.3 | 0.3 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.3 | 1.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.3 | 1.9 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.3 | 1.1 | GO:0016246 | RNA interference(GO:0016246) |
0.3 | 0.3 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.3 | 1.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.3 | 0.8 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 0.5 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.3 | 2.7 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.3 | 2.7 | GO:0045214 | sarcomere organization(GO:0045214) |
0.3 | 1.8 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.3 | 1.1 | GO:0051775 | response to redox state(GO:0051775) |
0.3 | 0.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.3 | 0.8 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.3 | 0.8 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.3 | 0.5 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.3 | 0.8 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.3 | 0.3 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.3 | 0.5 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.3 | 1.6 | GO:0050860 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.3 | 1.0 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.3 | 0.5 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.3 | 0.3 | GO:0034763 | negative regulation of transmembrane transport(GO:0034763) |
0.3 | 5.4 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.3 | 0.3 | GO:0002888 | positive regulation of myeloid leukocyte mediated immunity(GO:0002888) |
0.3 | 0.5 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.3 | 0.8 | GO:0052803 | histidine metabolic process(GO:0006547) imidazole-containing compound metabolic process(GO:0052803) |
0.3 | 0.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.3 | 1.0 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.3 | 1.8 | GO:0001967 | suckling behavior(GO:0001967) |
0.3 | 3.8 | GO:0046131 | pyrimidine ribonucleoside metabolic process(GO:0046131) |
0.2 | 0.2 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.2 | 2.0 | GO:0034505 | tooth mineralization(GO:0034505) |
0.2 | 2.5 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.2 | 0.5 | GO:0090208 | positive regulation of triglyceride catabolic process(GO:0010898) positive regulation of triglyceride metabolic process(GO:0090208) |
0.2 | 0.7 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.2 | 0.7 | GO:1903426 | regulation of nitric oxide biosynthetic process(GO:0045428) regulation of reactive oxygen species biosynthetic process(GO:1903426) |
0.2 | 0.7 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 1.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 0.7 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.2 | 3.4 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.2 | 1.2 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.2 | 2.2 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.2 | 0.2 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.2 | 0.5 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 0.5 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.2 | 3.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.2 | 0.9 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.2 | 0.9 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.2 | 0.2 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.2 | 2.3 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.2 | 1.9 | GO:0051319 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.2 | 0.5 | GO:0010523 | negative regulation of calcium ion transport into cytosol(GO:0010523) |
0.2 | 0.5 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.2 | 0.5 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.2 | 0.7 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.2 | 2.3 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.2 | 2.6 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.2 | 2.8 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
0.2 | 0.7 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 0.5 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.2 | 1.4 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.2 | 0.7 | GO:0031167 | rRNA methylation(GO:0031167) |
0.2 | 0.5 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.2 | 0.9 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.2 | 0.9 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 2.5 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.2 | 0.5 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 0.2 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.2 | 0.7 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.2 | 0.4 | GO:0002830 | positive regulation of type 2 immune response(GO:0002830) |
0.2 | 1.6 | GO:0051294 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.2 | 0.4 | GO:0042161 | plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.2 | 1.5 | GO:0098581 | detection of external biotic stimulus(GO:0098581) |
0.2 | 3.3 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 0.6 | GO:0046618 | drug export(GO:0046618) |
0.2 | 0.6 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.2 | 2.8 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.2 | 1.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 0.2 | GO:0090329 | regulation of DNA-dependent DNA replication(GO:0090329) |
0.2 | 0.8 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.4 | GO:0010823 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.2 | 0.4 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.2 | 0.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.2 | 1.0 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 1.4 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 0.6 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.2 | 0.6 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.2 | 1.4 | GO:0015884 | folic acid transport(GO:0015884) |
0.2 | 0.4 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.2 | 0.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.2 | 0.6 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.2 | 0.6 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.2 | 0.2 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.2 | 1.0 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.2 | 1.4 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.2 | 0.6 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.2 | 1.0 | GO:0045217 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
0.2 | 0.4 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.2 | 1.0 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.2 | 0.4 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.2 | 3.5 | GO:0030010 | establishment of cell polarity(GO:0030010) |
0.2 | 2.5 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 3.6 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.2 | 0.2 | GO:0045980 | negative regulation of nucleotide metabolic process(GO:0045980) |
0.2 | 0.4 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 0.6 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.2 | 0.2 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.2 | 1.9 | GO:0051806 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.2 | 0.6 | GO:0008615 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.2 | 0.4 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 0.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.2 | 0.4 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.2 | 1.1 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.2 | 2.3 | GO:1905037 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.2 | 0.9 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.2 | 0.6 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 0.8 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.2 | 1.1 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.2 | 0.4 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.2 | 0.2 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.2 | 1.1 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.2 | 0.2 | GO:0010524 | regulation of calcium ion transport into cytosol(GO:0010522) positive regulation of calcium ion transport into cytosol(GO:0010524) |
0.2 | 0.7 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 1.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 23.5 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.2 | 0.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.2 | 0.5 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.2 | 0.4 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.2 | 0.5 | GO:0031000 | response to caffeine(GO:0031000) |
0.2 | 0.4 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.2 | 0.2 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.2 | 0.5 | GO:0003341 | cilium movement(GO:0003341) |
0.2 | 0.3 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.2 | 0.7 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.2 | 0.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 0.5 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.2 | 0.5 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.2 | 0.7 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.2 | 1.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 0.3 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.2 | 2.2 | GO:0018904 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.2 | 0.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 0.3 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 0.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.2 | 0.8 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 0.2 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.2 | 1.2 | GO:0042116 | macrophage activation(GO:0042116) |
0.2 | 1.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 0.2 | GO:0006837 | serotonin transport(GO:0006837) |
0.2 | 0.3 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.2 | 0.7 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 1.8 | GO:0009083 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 0.5 | GO:0071569 | protein ufmylation(GO:0071569) |
0.2 | 0.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.2 | 0.2 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.2 | 0.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.2 | 0.6 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 0.2 | GO:0090197 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.2 | 0.3 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.2 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.2 | 1.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.2 | 0.5 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.2 | 0.5 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.2 | 0.8 | GO:0016233 | telomere capping(GO:0016233) |
0.2 | 0.2 | GO:0046084 | purine ribonucleoside salvage(GO:0006166) adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.2 | 0.9 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 0.6 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.2 | 0.6 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.2 | 0.3 | GO:0051299 | centrosome separation(GO:0051299) |
0.2 | 0.3 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 0.2 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.2 | 0.2 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.2 | 0.6 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 0.8 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 0.3 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.2 | 0.2 | GO:0021779 | oligodendrocyte cell fate commitment(GO:0021779) |
0.2 | 0.2 | GO:0090382 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
0.2 | 0.5 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.2 | 0.5 | GO:0032328 | alanine transport(GO:0032328) |
0.1 | 0.6 | GO:1904894 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.1 | 1.3 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 0.6 | GO:1900087 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.1 | 0.7 | GO:0032607 | interferon-alpha production(GO:0032607) regulation of interferon-alpha production(GO:0032647) |
0.1 | 0.9 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 8.2 | GO:0019395 | fatty acid oxidation(GO:0019395) lipid oxidation(GO:0034440) |
0.1 | 0.4 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.6 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.1 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.1 | 0.4 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.7 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 1.0 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 0.1 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.1 | 0.1 | GO:0042522 | tyrosine phosphorylation of Stat5 protein(GO:0042506) regulation of tyrosine phosphorylation of Stat5 protein(GO:0042522) |
0.1 | 0.4 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 0.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 2.3 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.1 | 0.4 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.3 | GO:1904358 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.1 | 0.6 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 1.4 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.1 | 0.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 2.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 2.1 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.1 | 0.6 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.1 | 0.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.8 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.4 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.1 | 0.6 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.8 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 1.5 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) G1 DNA damage checkpoint(GO:0044783) mitotic G1/S transition checkpoint(GO:0044819) |
0.1 | 0.8 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 3.3 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.1 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.1 | 0.4 | GO:1901889 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.1 | 3.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.4 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.1 | 0.3 | GO:0051298 | centrosome duplication(GO:0051298) |
0.1 | 0.5 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.1 | GO:1904748 | regulation of apoptotic process involved in morphogenesis(GO:1902337) regulation of apoptotic process involved in development(GO:1904748) |
0.1 | 0.1 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.1 | 0.5 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.1 | 0.3 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.1 | 0.5 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.7 | GO:0032770 | positive regulation of monooxygenase activity(GO:0032770) |
0.1 | 0.4 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.1 | GO:1904478 | regulation of intestinal cholesterol absorption(GO:0030300) negative regulation of digestive system process(GO:0060457) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
0.1 | 3.7 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.1 | 0.3 | GO:1902170 | cellular response to nitric oxide(GO:0071732) cellular response to reactive nitrogen species(GO:1902170) |
0.1 | 0.4 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 0.4 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 2.5 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 2.3 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.1 | 0.3 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.6 | GO:0003044 | regulation of systemic arterial blood pressure mediated by a chemical signal(GO:0003044) |
0.1 | 0.5 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.5 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.1 | 0.4 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.1 | 0.3 | GO:0071600 | otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.1 | 0.4 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.1 | 0.5 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.2 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.1 | 0.2 | GO:2000328 | T-helper cell lineage commitment(GO:0002295) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) memory T cell differentiation(GO:0043379) regulation of memory T cell differentiation(GO:0043380) positive regulation of memory T cell differentiation(GO:0043382) T-helper 17 type immune response(GO:0072538) T-helper 17 cell differentiation(GO:0072539) T-helper 17 cell lineage commitment(GO:0072540) regulation of T-helper 17 type immune response(GO:2000316) positive regulation of T-helper 17 type immune response(GO:2000318) regulation of T-helper 17 cell differentiation(GO:2000319) positive regulation of T-helper 17 cell differentiation(GO:2000321) regulation of T-helper 17 cell lineage commitment(GO:2000328) positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
0.1 | 0.2 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.1 | 0.2 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.1 | 0.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.7 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.1 | 0.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.1 | GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
0.1 | 0.4 | GO:0099518 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.1 | 2.2 | GO:0009617 | response to bacterium(GO:0009617) |
0.1 | 1.1 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.1 | 0.1 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.1 | 0.2 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.1 | 1.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.6 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.1 | 0.6 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.2 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.1 | GO:0070293 | renal absorption(GO:0070293) |
0.1 | 0.4 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 0.5 | GO:0072665 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.1 | 2.3 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 1.1 | GO:0031100 | organ regeneration(GO:0031100) |
0.1 | 0.2 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.1 | 0.6 | GO:0090398 | cellular senescence(GO:0090398) |
0.1 | 0.2 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 0.8 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.1 | 0.5 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.1 | 0.5 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 4.1 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.1 | 1.5 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.1 | 0.8 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.3 | GO:0030431 | sleep(GO:0030431) |
0.1 | 1.5 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.7 | GO:0034661 | ncRNA catabolic process(GO:0034661) |
0.1 | 0.3 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.1 | 0.3 | GO:0021781 | glial cell fate commitment(GO:0021781) |
0.1 | 0.5 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.1 | 0.4 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.1 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.1 | GO:0070198 | protein localization to chromosome, telomeric region(GO:0070198) |
0.1 | 0.1 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.1 | 0.1 | GO:2000379 | positive regulation of reactive oxygen species metabolic process(GO:2000379) |
0.1 | 0.6 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.2 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 1.6 | GO:0010043 | response to zinc ion(GO:0010043) |
0.1 | 0.1 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 0.2 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 5.3 | GO:0006826 | iron ion transport(GO:0006826) |
0.1 | 0.2 | GO:1901798 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 1.0 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 2.4 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.1 | 0.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.4 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.6 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.7 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.1 | 0.3 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.1 | 5.0 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.1 | 0.7 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.1 | GO:0051155 | positive regulation of myotube differentiation(GO:0010831) positive regulation of striated muscle cell differentiation(GO:0051155) |
0.1 | 0.2 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.9 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.9 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.1 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.1 | 0.4 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.1 | 0.4 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.4 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.3 | GO:0051324 | prophase(GO:0051324) |
0.1 | 2.3 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.2 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.1 | 0.5 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 1.0 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.7 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.1 | 0.1 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.4 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.2 | GO:0010743 | regulation of macrophage derived foam cell differentiation(GO:0010743) |
0.1 | 0.8 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 0.9 | GO:0019320 | hexose catabolic process(GO:0019320) |
0.1 | 0.6 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.3 | GO:0045006 | DNA deamination(GO:0045006) |
0.1 | 1.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.4 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 0.3 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 1.9 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.7 | GO:0046622 | positive regulation of organ growth(GO:0046622) |
0.1 | 4.9 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.1 | 0.2 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.1 | 0.5 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.1 | 0.9 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.6 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.9 | GO:0007033 | vacuole organization(GO:0007033) |
0.1 | 0.5 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.1 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 0.1 | GO:0044773 | mitotic DNA damage checkpoint(GO:0044773) |
0.1 | 0.3 | GO:0060009 | Sertoli cell differentiation(GO:0060008) Sertoli cell development(GO:0060009) |
0.1 | 0.4 | GO:0000050 | urea cycle(GO:0000050) |
0.1 | 1.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 3.4 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.3 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.1 | 0.9 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.1 | 3.1 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.1 | 0.4 | GO:0051238 | sequestering of metal ion(GO:0051238) |
0.1 | 0.2 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.5 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.1 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.1 | 0.9 | GO:0006385 | transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
0.1 | 0.3 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.1 | 0.1 | GO:0010269 | response to selenium ion(GO:0010269) |
0.1 | 2.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.9 | GO:0060079 | excitatory postsynaptic potential(GO:0060079) |
0.1 | 0.5 | GO:0015840 | urea transport(GO:0015840) |
0.1 | 0.8 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 0.2 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 1.1 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.1 | 0.5 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 0.3 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.8 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 4.5 | GO:0007586 | digestion(GO:0007586) |
0.1 | 0.2 | GO:0046831 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.1 | GO:0015669 | gas transport(GO:0015669) |
0.1 | 0.1 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 0.6 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.2 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.1 | 0.2 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 2.0 | GO:0046364 | monosaccharide biosynthetic process(GO:0046364) |
0.1 | 0.4 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.2 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.1 | 2.6 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.7 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.1 | 0.2 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.1 | 0.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 0.5 | GO:0007620 | copulation(GO:0007620) |
0.1 | 10.7 | GO:0006813 | potassium ion transport(GO:0006813) |
0.1 | 0.4 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.6 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 2.6 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.1 | 0.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 2.8 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
0.1 | 0.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.1 | GO:0071801 | podosome assembly(GO:0071800) regulation of podosome assembly(GO:0071801) positive regulation of podosome assembly(GO:0071803) |
0.1 | 28.1 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.1 | 0.1 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) positive regulation of meiotic cell cycle(GO:0051446) |
0.1 | 0.1 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 0.3 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.3 | GO:0007099 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.1 | 1.0 | GO:0042246 | tissue regeneration(GO:0042246) |
0.1 | 0.1 | GO:0060677 | ureteric bud elongation(GO:0060677) renal vesicle formation(GO:0072033) |
0.1 | 0.3 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.1 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.1 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 0.5 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.9 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.1 | 0.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 1.0 | GO:0048477 | oogenesis(GO:0048477) |
0.1 | 0.7 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
0.1 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.3 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 1.0 | GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition(GO:0051437) |
0.1 | 0.6 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.8 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.1 | 0.6 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.1 | 0.1 | GO:0048541 | Peyer's patch development(GO:0048541) |
0.1 | 0.7 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.1 | 1.2 | GO:0030856 | regulation of epithelial cell differentiation(GO:0030856) |
0.1 | 0.2 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.1 | GO:0090037 | regulation of protein kinase C signaling(GO:0090036) positive regulation of protein kinase C signaling(GO:0090037) |
0.1 | 0.3 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.1 | 0.2 | GO:0010226 | response to lithium ion(GO:0010226) |
0.1 | 0.3 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.1 | 0.7 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.2 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.1 | 0.5 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.1 | 0.2 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.1 | 0.1 | GO:0010985 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) negative regulation of lipoprotein particle clearance(GO:0010985) |
0.1 | 1.3 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.1 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 0.1 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.1 | 0.4 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.1 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.4 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 0.1 | GO:0031641 | regulation of myelination(GO:0031641) |
0.1 | 0.2 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.1 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.1 | 0.2 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
0.1 | 0.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.6 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.1 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.7 | GO:0030317 | sperm motility(GO:0030317) |
0.1 | 1.3 | GO:0006490 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.7 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.1 | 0.1 | GO:0051705 | multi-organism behavior(GO:0051705) |
0.1 | 0.1 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 7.2 | GO:0045087 | innate immune response(GO:0045087) |
0.1 | 0.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.1 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 2.4 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 1.6 | GO:0000910 | cytokinesis(GO:0000910) |
0.1 | 0.2 | GO:0009151 | purine deoxyribonucleotide metabolic process(GO:0009151) |
0.1 | 0.5 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.8 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.0 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 1.2 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.0 | GO:0030239 | myofibril assembly(GO:0030239) |
0.0 | 0.4 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.0 | 0.2 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.1 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.0 | 0.1 | GO:0060841 | venous blood vessel development(GO:0060841) |
0.0 | 0.1 | GO:0060969 | negative regulation of gene silencing(GO:0060969) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.1 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.1 | GO:0016236 | macroautophagy(GO:0016236) |
0.0 | 0.1 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.0 | 0.0 | GO:0070977 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.0 | 0.2 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.0 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 2.9 | GO:0007187 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger(GO:0007187) |
0.0 | 0.0 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.1 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.6 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.0 | GO:0030146 | obsolete diuresis(GO:0030146) |
0.0 | 0.1 | GO:0006809 | nitric oxide biosynthetic process(GO:0006809) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 2.8 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.2 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.0 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.0 | 0.5 | GO:0007530 | sex determination(GO:0007530) |
0.0 | 0.0 | GO:0043486 | histone exchange(GO:0043486) |
0.0 | 0.9 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 0.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.1 | GO:0051955 | regulation of amino acid transport(GO:0051955) |
0.0 | 0.1 | GO:0003032 | detection of oxygen(GO:0003032) |
0.0 | 0.3 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.2 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.0 | 0.4 | GO:0046058 | cAMP metabolic process(GO:0046058) |
0.0 | 0.0 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.0 | 1.3 | GO:0046777 | protein autophosphorylation(GO:0046777) |
0.0 | 0.0 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
0.0 | 0.1 | GO:0033133 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.1 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.2 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
0.0 | 0.0 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.5 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.4 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 1.0 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) actin-mediated cell contraction(GO:0070252) |
0.0 | 0.2 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.0 | 0.7 | GO:0048193 | Golgi vesicle transport(GO:0048193) |
0.0 | 1.2 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 0.4 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.0 | 0.1 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.0 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.0 | 1.0 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
0.0 | 0.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.1 | GO:0072081 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
0.0 | 0.1 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.1 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.0 | 0.0 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.1 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.0 | 4.2 | GO:0007186 | G-protein coupled receptor signaling pathway(GO:0007186) |
0.0 | 0.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.1 | GO:0048265 | response to pain(GO:0048265) |
0.0 | 0.1 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.0 | 0.6 | GO:1904029 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.0 | 0.3 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.0 | 0.1 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.0 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.0 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.0 | GO:0043558 | regulation of translation in response to stress(GO:0043555) regulation of translational initiation in response to stress(GO:0043558) |
0.0 | 0.0 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.0 | 0.0 | GO:0021756 | striatum development(GO:0021756) |
0.0 | 0.1 | GO:0031274 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.0 | GO:0071622 | regulation of granulocyte chemotaxis(GO:0071622) |
0.0 | 0.0 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.1 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.0 | 0.4 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
0.0 | 0.4 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.0 | 0.0 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.0 | GO:0006531 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.0 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.0 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.0 | GO:0033238 | regulation of cellular amine metabolic process(GO:0033238) |
0.0 | 0.1 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.0 | 0.0 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.1 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.1 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.0 | GO:0002714 | positive regulation of B cell mediated immunity(GO:0002714) positive regulation of immunoglobulin mediated immune response(GO:0002891) |
0.0 | 0.0 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.0 | 0.0 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
0.0 | 0.0 | GO:0002922 | positive regulation of humoral immune response(GO:0002922) |
0.0 | 0.0 | GO:0001839 | neural plate morphogenesis(GO:0001839) neural plate development(GO:0001840) |
0.0 | 0.0 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 0.1 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.0 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.1 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.0 | 0.1 | GO:0009308 | amine metabolic process(GO:0009308) |
0.0 | 0.1 | GO:0006195 | purine nucleotide catabolic process(GO:0006195) |
0.0 | 0.0 | GO:0042044 | fluid transport(GO:0042044) |
0.0 | 0.3 | GO:0007219 | Notch signaling pathway(GO:0007219) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.8 | 2.5 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.8 | 4.0 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.7 | 2.9 | GO:0033268 | node of Ranvier(GO:0033268) |
0.7 | 2.2 | GO:0032009 | early phagosome(GO:0032009) |
0.7 | 2.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.7 | 6.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.7 | 4.0 | GO:0042581 | specific granule(GO:0042581) |
0.6 | 1.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.6 | 1.8 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.6 | 1.8 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.6 | 1.8 | GO:0042584 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.6 | 1.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.6 | 3.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.5 | 2.2 | GO:0001740 | Barr body(GO:0001740) |
0.5 | 1.6 | GO:0033270 | paranode region of axon(GO:0033270) |
0.5 | 2.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.5 | 4.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.5 | 1.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.5 | 3.6 | GO:0000145 | exocyst(GO:0000145) |
0.4 | 1.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.4 | 2.1 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.4 | 2.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.4 | 11.6 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.4 | 1.5 | GO:0071547 | piP-body(GO:0071547) |
0.4 | 1.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.4 | 1.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.4 | 2.5 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.4 | 1.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.4 | 2.8 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 1.0 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.3 | 1.0 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.3 | 2.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 3.7 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.3 | 3.3 | GO:0030315 | T-tubule(GO:0030315) |
0.3 | 1.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 1.8 | GO:0001527 | microfibril(GO:0001527) |
0.3 | 3.5 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.3 | 2.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.3 | 1.1 | GO:0043218 | compact myelin(GO:0043218) |
0.3 | 1.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 0.6 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.3 | 1.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.3 | 0.8 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.3 | 0.5 | GO:0030870 | Mre11 complex(GO:0030870) |
0.3 | 1.1 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.3 | 0.8 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.3 | 1.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.3 | 5.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.3 | 2.0 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.3 | 0.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 1.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 1.5 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 2.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.2 | 0.2 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.2 | 1.4 | GO:0032590 | dendrite membrane(GO:0032590) |
0.2 | 0.9 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 0.2 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 0.7 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 1.1 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 3.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 0.7 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.2 | 0.9 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.2 | 0.9 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 1.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 0.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 0.9 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.2 | 0.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 1.1 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.2 | 6.6 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.2 | 0.4 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 1.9 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 1.6 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 1.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.2 | 0.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 0.6 | GO:0031012 | extracellular matrix(GO:0031012) |
0.2 | 4.2 | GO:0001533 | cornified envelope(GO:0001533) |
0.2 | 1.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 1.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 0.4 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 4.6 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 1.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 0.6 | GO:0000930 | gamma-tubulin complex(GO:0000930) gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.2 | 0.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 2.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 1.5 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.2 | 0.7 | GO:0000800 | lateral element(GO:0000800) |
0.2 | 9.5 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 8.5 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 0.5 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 0.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.4 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.2 | 9.2 | GO:0016605 | PML body(GO:0016605) |
0.2 | 0.7 | GO:0042627 | chylomicron(GO:0042627) |
0.2 | 1.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 0.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 0.8 | GO:0031083 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.2 | 1.3 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 2.1 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 1.0 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 0.7 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 0.8 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.2 | 1.8 | GO:0043034 | costamere(GO:0043034) |
0.2 | 0.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 0.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 0.6 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 1.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 0.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.2 | 1.4 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 0.2 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.2 | 2.9 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 0.6 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.2 | 12.1 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.2 | 1.1 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 4.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.9 | GO:0099738 | cell cortex region(GO:0099738) |
0.1 | 0.7 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.1 | 0.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 10.7 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 1.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.7 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 0.5 | GO:0001520 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.1 | 0.4 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 0.3 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 1.6 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.4 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 6.2 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 1.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.1 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.6 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 1.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 2.1 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 1.1 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 1.0 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 1.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.5 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.2 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 0.4 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 1.6 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 3.2 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 0.6 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.5 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 0.6 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.6 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.1 | 7.7 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.6 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.3 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.1 | 1.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.5 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 1.2 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 2.9 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 11.8 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 0.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.5 | GO:0030133 | transport vesicle(GO:0030133) |
0.1 | 1.9 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 3.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.3 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 0.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.2 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.1 | 1.8 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 8.9 | GO:0099503 | secretory vesicle(GO:0099503) |
0.1 | 4.4 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.5 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 3.1 | GO:0034708 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.1 | 0.6 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 1.1 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.7 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 6.7 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 8.3 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.9 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 1.9 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 2.1 | GO:0019867 | outer membrane(GO:0019867) |
0.1 | 1.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 1.1 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 9.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.2 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 2.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.9 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 0.9 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 0.5 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 4.1 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 1.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 2.6 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 2.3 | GO:1902493 | histone acetyltransferase complex(GO:0000123) protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.1 | 0.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 1.3 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 4.3 | GO:0019717 | obsolete synaptosome(GO:0019717) |
0.1 | 6.1 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 5.1 | GO:0005624 | obsolete membrane fraction(GO:0005624) |
0.1 | 282.2 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 0.5 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 33.4 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 11.1 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.1 | 0.5 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 1.9 | GO:0031975 | envelope(GO:0031975) |
0.1 | 0.4 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 0.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.9 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.1 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.5 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.4 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 0.1 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.0 | 0.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.6 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.2 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.4 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 0.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.4 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.4 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.3 | GO:0030663 | COPI vesicle coat(GO:0030126) COPI-coated vesicle membrane(GO:0030663) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.1 | GO:0043205 | fibril(GO:0043205) |
0.0 | 1.1 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.9 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 1.4 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.8 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.3 | GO:0000792 | heterochromatin(GO:0000792) |
0.0 | 0.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.4 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.0 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.2 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.0 | 0.5 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 0.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 19.4 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 0.6 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 0.0 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.1 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.0 | 0.2 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.1 | GO:0045277 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) |
0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.0 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 12.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.1 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.1 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.4 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.0 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.1 | GO:0031252 | cell leading edge(GO:0031252) |
0.0 | 0.0 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.6 | GO:0005792 | obsolete microsome(GO:0005792) |
0.0 | 0.4 | GO:0005819 | spindle(GO:0005819) |
0.0 | 11.0 | GO:0005829 | cytosol(GO:0005829) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 8.5 | GO:0050544 | arachidonic acid binding(GO:0050544) |
1.7 | 12.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
1.7 | 5.0 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
1.4 | 4.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
1.2 | 5.0 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
1.1 | 5.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.1 | 3.3 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
1.0 | 9.4 | GO:0019864 | IgG binding(GO:0019864) |
1.0 | 3.1 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
1.0 | 3.1 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
1.0 | 4.1 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
1.0 | 3.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.9 | 3.6 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.9 | 2.7 | GO:0004875 | complement receptor activity(GO:0004875) |
0.9 | 3.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.8 | 2.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.8 | 3.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.8 | 5.8 | GO:0000339 | RNA cap binding(GO:0000339) |
0.8 | 0.8 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.8 | 6.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.8 | 3.0 | GO:0051425 | PTB domain binding(GO:0051425) |
0.8 | 2.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.7 | 3.7 | GO:0001846 | opsonin binding(GO:0001846) |
0.7 | 4.5 | GO:0046790 | virion binding(GO:0046790) |
0.7 | 2.9 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.7 | 3.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.7 | 3.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.7 | 4.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.7 | 2.1 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.7 | 2.1 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.7 | 2.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.7 | 4.0 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.7 | 4.6 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.6 | 2.6 | GO:0004340 | glucokinase activity(GO:0004340) |
0.6 | 3.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.6 | 0.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.6 | 0.6 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.6 | 0.6 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.6 | 1.9 | GO:0043559 | insulin binding(GO:0043559) |
0.6 | 2.5 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.6 | 4.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.6 | 1.8 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.6 | 2.4 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.6 | 1.8 | GO:0035197 | siRNA binding(GO:0035197) |
0.6 | 2.4 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.6 | 1.8 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.6 | 4.0 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.6 | 2.8 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.6 | 3.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.6 | 1.7 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.6 | 2.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.5 | 2.7 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.5 | 1.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.5 | 5.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.5 | 3.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.5 | 1.0 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.5 | 1.6 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.5 | 1.5 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.5 | 1.5 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.5 | 2.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.5 | 6.5 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.5 | 1.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.5 | 1.9 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.5 | 1.4 | GO:0030354 | melanin-concentrating hormone activity(GO:0030354) |
0.5 | 1.4 | GO:0000987 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.5 | 1.9 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.5 | 7.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.5 | 1.9 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.5 | 1.4 | GO:0004556 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
0.5 | 1.4 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.5 | 3.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.5 | 4.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.5 | 2.3 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.5 | 1.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.5 | 1.4 | GO:0004739 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.5 | 1.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.4 | 0.9 | GO:0016151 | nickel cation binding(GO:0016151) |
0.4 | 0.9 | GO:0034648 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.4 | 0.9 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.4 | 1.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.4 | 1.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 3.9 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.4 | 2.6 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.4 | 8.7 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.4 | 1.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.4 | 1.3 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.4 | 7.4 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.4 | 3.0 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.4 | 3.9 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.4 | 3.4 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.4 | 1.7 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.4 | 2.1 | GO:0005536 | glucose binding(GO:0005536) |
0.4 | 2.6 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.4 | 1.3 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.4 | 1.7 | GO:0030955 | potassium ion binding(GO:0030955) |
0.4 | 0.4 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.4 | 2.9 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.4 | 1.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.4 | 3.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.4 | 6.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.4 | 1.6 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.4 | 2.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.4 | 1.2 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.4 | 1.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.4 | 1.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.4 | 2.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.4 | 2.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.4 | 1.2 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.4 | 0.8 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.4 | 1.9 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.4 | 0.7 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.4 | 0.4 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.4 | 16.8 | GO:0008009 | chemokine activity(GO:0008009) |
0.4 | 1.1 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.4 | 1.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.4 | 1.8 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.4 | 1.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.4 | 5.9 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.4 | 0.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.4 | 1.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 3.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.4 | 0.7 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.4 | 0.7 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.4 | 1.8 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.4 | 1.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 1.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 1.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.3 | 1.0 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.3 | 0.7 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.3 | 0.3 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.3 | 2.7 | GO:0071617 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.3 | 2.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 1.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.3 | 1.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 1.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.3 | 1.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.3 | 1.0 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.3 | 1.7 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.3 | 1.0 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.3 | 1.7 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.3 | 1.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.3 | 2.0 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.3 | 1.0 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.3 | 1.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.3 | 2.3 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.3 | 1.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.3 | 0.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.3 | 8.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.3 | 1.3 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 0.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.3 | 2.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 0.9 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 1.2 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.3 | 1.8 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.3 | 0.9 | GO:0008061 | chitin binding(GO:0008061) |
0.3 | 0.9 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 2.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.3 | 1.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.3 | 1.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 0.3 | GO:0042287 | MHC protein binding(GO:0042287) |
0.3 | 0.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.3 | 0.6 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.3 | 0.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 4.4 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.3 | 0.6 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.3 | 1.7 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.3 | 6.7 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.3 | 3.2 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.3 | 1.7 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.3 | 0.9 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.3 | 0.8 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.3 | 3.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.3 | 0.3 | GO:0070405 | ammonium ion binding(GO:0070405) |
0.3 | 0.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.3 | 0.8 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.3 | 1.9 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.3 | 0.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 1.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.3 | 0.8 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.3 | 0.8 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.3 | 0.8 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.3 | 0.8 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.3 | 0.5 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.3 | 0.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.3 | 1.0 | GO:0070402 | NADPH binding(GO:0070402) |
0.3 | 3.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.3 | 1.8 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.3 | 1.6 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.3 | 0.3 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.3 | 2.3 | GO:0030553 | cGMP binding(GO:0030553) |
0.3 | 1.3 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.3 | 2.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.3 | 1.0 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.3 | 0.5 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.3 | 2.3 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.2 | 0.7 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 3.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 2.0 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.2 | 0.7 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.2 | 1.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.2 | 1.5 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.2 | 0.7 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 0.7 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 3.3 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.2 | 0.7 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 2.1 | GO:0030276 | clathrin binding(GO:0030276) |
0.2 | 1.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 1.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 0.5 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 0.9 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.2 | 0.2 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.2 | 1.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 1.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 5.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.2 | 0.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.2 | 1.8 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.2 | 4.0 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.2 | 0.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 1.5 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.2 | 0.9 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 0.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 2.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 0.6 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 0.8 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.2 | 0.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 5.2 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.2 | 0.6 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.2 | 1.9 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 10.2 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.2 | 1.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.2 | 0.4 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 1.0 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 0.6 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 0.2 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.2 | 1.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 5.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 1.6 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.2 | 1.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.6 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.2 | 2.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 1.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.2 | 0.4 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.2 | 0.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 0.4 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.2 | 0.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 0.6 | GO:0002054 | nucleobase binding(GO:0002054) |
0.2 | 1.9 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.2 | 1.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 1.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 0.6 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.2 | 0.8 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.2 | 1.1 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.2 | 0.4 | GO:0019956 | chemokine binding(GO:0019956) |
0.2 | 0.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 1.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 2.8 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.2 | 1.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 1.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 0.4 | GO:0045159 | myosin II binding(GO:0045159) |
0.2 | 0.5 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 0.4 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.2 | 1.6 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.2 | 0.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 1.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 0.9 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 1.0 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.2 | 0.9 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 0.5 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 0.9 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 9.1 | GO:0051015 | actin filament binding(GO:0051015) |
0.2 | 1.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 1.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 0.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.2 | 0.5 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.2 | 3.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 0.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 0.5 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.2 | 4.2 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 1.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 0.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.2 | 0.3 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.2 | 0.7 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 0.5 | GO:0035240 | dopamine binding(GO:0035240) |
0.2 | 1.0 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.2 | 0.5 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.2 | 0.6 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.2 | 1.0 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.2 | 0.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 2.9 | GO:0017022 | myosin binding(GO:0017022) |
0.2 | 0.5 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.2 | 0.5 | GO:0016208 | AMP binding(GO:0016208) |
0.2 | 0.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.2 | 5.3 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.2 | 0.8 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 0.5 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.2 | 2.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 2.8 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 0.2 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) |
0.2 | 0.5 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 0.3 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 0.6 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.2 | 0.6 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.2 | 0.9 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 0.6 | GO:0034979 | NAD-dependent histone deacetylase activity(GO:0017136) histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H3-K9 specific)(GO:0032129) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent protein deacetylase activity(GO:0034979) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.2 | 0.5 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.2 | 0.5 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.9 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.4 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 34.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 1.9 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.1 | 0.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 3.1 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 12.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.4 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 1.4 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.6 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.4 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 2.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.4 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.7 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.6 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.4 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.8 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.6 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 3.3 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 0.5 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 3.2 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 1.1 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 1.1 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.1 | 1.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.5 | GO:0080031 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.1 | 0.1 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 3.4 | GO:0005506 | iron ion binding(GO:0005506) |
0.1 | 0.6 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 2.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.4 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 1.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 0.1 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 2.8 | GO:0019825 | oxygen binding(GO:0019825) |
0.1 | 4.2 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.1 | 0.4 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.5 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.1 | 0.8 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 1.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 2.4 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 2.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.1 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.1 | 0.8 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.5 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.4 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.1 | 2.1 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.9 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 1.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.6 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.6 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 1.3 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.7 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.5 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 0.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.5 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 0.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.7 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.9 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.1 | 0.2 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.5 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.7 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.9 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.8 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.8 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 1.0 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.5 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.1 | 0.5 | GO:0061630 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.1 | 1.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 6.9 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.3 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 2.5 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.3 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.5 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 1.6 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 0.2 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.1 | 0.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 17.0 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 5.1 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.1 | 1.5 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.1 | 0.6 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.2 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 1.9 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.1 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.1 | 0.2 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 28.0 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 0.4 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.1 | 0.6 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.1 | 0.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.6 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 6.0 | GO:0016566 | obsolete specific transcriptional repressor activity(GO:0016566) |
0.1 | 2.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.1 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.5 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.8 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.5 | GO:0101005 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 2.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 1.7 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 1.7 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.4 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.6 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.4 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.1 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 0.2 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 0.5 | GO:0016986 | obsolete transcription initiation factor activity(GO:0016986) |
0.1 | 1.0 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 6.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.5 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 1.0 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.1 | 0.6 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.9 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.2 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.1 | 0.5 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 1.9 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 1.6 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 0.2 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.3 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.7 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.1 | GO:0001012 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.0 | 0.2 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 0.4 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 1.3 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.5 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.0 | 0.0 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.0 | 3.8 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.1 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 1.9 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 0.9 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.1 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) amidine-lyase activity(GO:0016842) |
0.0 | 1.3 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 0.7 | GO:0050661 | NADP binding(GO:0050661) |
0.0 | 0.2 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.2 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 3.1 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.3 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.5 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.1 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.0 | 0.3 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.1 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.3 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.1 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.3 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 2.9 | GO:0016757 | transferase activity, transferring glycosyl groups(GO:0016757) |
0.0 | 8.0 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.2 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 1.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.4 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.0 | 0.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.6 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.1 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.7 | GO:0034061 | DNA-directed DNA polymerase activity(GO:0003887) DNA polymerase activity(GO:0034061) |
0.0 | 1.7 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.8 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.0 | 0.1 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.2 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 2.8 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.6 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 0.0 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.0 | 0.0 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.0 | 0.2 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.2 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 2.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.0 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.0 | 8.7 | GO:0004872 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
0.0 | 0.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.0 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.1 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.0 | GO:0032451 | demethylase activity(GO:0032451) |
0.0 | 0.0 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.0 | 0.0 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 24.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.7 | 2.8 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.6 | 1.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.6 | 19.9 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.6 | 5.9 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.6 | 6.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.6 | 1.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.6 | 1.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.5 | 0.5 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.5 | 3.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.4 | 4.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.4 | 0.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.4 | 0.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.3 | 0.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 8.5 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 3.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.3 | 5.1 | PID ARF 3PATHWAY | Arf1 pathway |
0.3 | 2.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.3 | 1.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.3 | 7.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 4.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 1.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 3.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 0.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 1.5 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.2 | 1.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 2.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 2.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 8.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 3.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 6.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 11.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 2.8 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 0.8 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 0.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 0.8 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 0.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 2.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 3.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 2.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 0.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 28.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 0.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 2.6 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 1.7 | ST ADRENERGIC | Adrenergic Pathway |
0.2 | 1.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 1.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 2.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 1.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 0.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 0.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 1.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 2.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 2.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 2.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.7 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 3.9 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 1.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 3.0 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.3 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 3.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 4.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 1.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 27.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 2.6 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 1.0 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 16.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 1.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 2.6 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 1.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 2.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 1.1 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 2.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 0.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 1.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 2.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 0.4 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.7 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.8 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.5 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.4 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.9 | 11.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.9 | 3.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.7 | 8.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.7 | 1.4 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.7 | 0.7 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.6 | 2.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.6 | 2.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.5 | 7.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.5 | 12.1 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.5 | 6.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.5 | 6.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.5 | 4.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.4 | 4.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.4 | 5.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.4 | 0.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.4 | 2.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.4 | 3.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.4 | 15.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.4 | 1.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.4 | 7.8 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.4 | 7.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.4 | 7.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.3 | 2.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 1.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 4.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.3 | 3.0 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.3 | 6.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 0.7 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.3 | 2.7 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 3.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.3 | 1.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 4.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.3 | 2.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 6.1 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.3 | 9.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.3 | 2.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 3.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.3 | 8.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.3 | 0.6 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.3 | 3.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.3 | 2.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 3.9 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 2.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.3 | 0.3 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.3 | 6.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.3 | 16.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.3 | 2.6 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.3 | 5.1 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.3 | 1.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.3 | 0.3 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.3 | 2.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 8.9 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 1.7 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.2 | 3.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 2.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 2.9 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.2 | 10.4 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.2 | 11.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 3.6 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 2.9 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 0.5 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 2.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.2 | 2.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 6.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 1.1 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 5.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 4.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 1.0 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 2.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 4.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 1.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 14.9 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.2 | 1.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.2 | 5.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 0.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 0.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 8.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.2 | 0.7 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 2.1 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.2 | 10.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 1.5 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 0.3 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.2 | 1.7 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 0.6 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.2 | 1.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 3.5 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.2 | 6.5 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 6.9 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 0.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 0.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 1.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 5.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 1.7 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 0.4 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 1.0 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 0.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 3.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 5.7 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 1.1 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 0.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 1.7 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 1.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 14.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 1.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 2.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 2.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 1.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 2.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 5.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 1.8 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 1.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 2.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 1.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 1.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 2.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.5 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 9.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 2.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.9 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 0.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 1.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 2.9 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.1 | 1.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.7 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 0.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.3 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 1.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.5 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 23.7 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 0.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 1.1 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 0.5 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 1.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 1.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.4 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 0.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.9 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 1.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 2.1 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 0.3 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 1.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.4 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.1 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 0.6 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 1.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.5 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.6 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.7 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.2 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.3 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 1.0 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.3 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.2 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.2 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.1 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.0 | 0.3 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.0 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.0 | 0.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.1 | REACTOME G1 S TRANSITION | Genes involved in G1/S Transition |
0.0 | 0.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.0 | REACTOME TRIF MEDIATED TLR3 SIGNALING | Genes involved in TRIF mediated TLR3 signaling |
0.0 | 0.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.2 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.6 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.1 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.0 | 0.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.3 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |